Found: 207
Select item for more details and to access through your institution.
Economic and Quality-of-Life Implications of Non-Alcoholic Fatty Liver Disease.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Chronic Hepatitis B Is Associated with Higher Inpatient Resource Utilization and Mortality Versus Chronic Hepatitis C.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Interferon-Free Regimens for Chronic Hepatitis C: Barriers Due to Treatment Candidacy and Insurance Coverage.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Demonstration of two types of fatigue in subjects with chronic liver disease using factor analysis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
PSYCHOMETRIC PROPERTIES OF THE CHRONIC LIVER DISEASE QUESTIONNAIRE IN PATIENTS WITH CHRONIC LIVER DISEASE.
- Published in:
- Journal of Basic & Clinical Health Sciences, 2023, v. 7, n. 2, p. 671, doi. 10.30621/jbachs.1170430
- By:
- Publication type:
- Article
Presumed Nonalcoholic Fatty Liver Disease Among Medicare Beneficiaries With HIV, 2006–2016.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 1, p. N.PAG, doi. 10.1093/ofid/ofz509
- By:
- Publication type:
- Article
The Portrait of an Adult Liver Transplant Recipient in the United States From 1987 to 2013.
- Published in:
- JAMA Internal Medicine, 2014, v. 174, n. 8, p. 1407, doi. 10.1001/jamainternmed.2014.2903
- By:
- Publication type:
- Article
Trends in Liver Transplantation in Hepatitis C Virus-Infected Persons, United States.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Quality-of-Life Assessments and Chronic Liver Disease.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 1998, v. 93, n. 7, p. 1037, doi. 10.1111/j.1572-0241.1998.00325.x
- By:
- Publication type:
- Article
The inpatient economic and mortality impact of hepatocellular carcinoma from 2005 to 2009: analysis of the US nationwide inpatient sample.
- Published in:
- Liver International, 2013, v. 33, n. 8, p. 1281, doi. 10.1111/liv.12201
- By:
- Publication type:
- Article
Gene expression profile associated with superimposed non-alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C.
- Published in:
- Liver International, 2009, v. 29, n. 9, p. 1403, doi. 10.1111/j.1478-3231.2009.02060.x
- By:
- Publication type:
- Article
INTRODUCTION.
- Published in:
- Liver International, 2009, v. 29, p. 1, doi. 10.1111/j.1478-3231.2008.01948.x
- By:
- Publication type:
- Article
Metabolic syndrome, non-alcoholic fatty liver disease and hepatitis C virus: impact on disease progression and treatment response.
- Published in:
- Liver International, 2009, v. 29, p. 3, doi. 10.1111/j.1478-3231.2008.01949.x
- By:
- Publication type:
- Article
Apnoeic–hypopnoeic episodes during obstructive sleep apnoea are associated with histological nonalcoholic steatohepatitis.
- Published in:
- Liver International, 2008, v. 28, n. 8, p. 1080, doi. 10.1111/j.1478-3231.2008.01822.x
- By:
- Publication type:
- Article
Reply:.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Health-related quality of life in patients with chronic hepatitis B.
- Published in:
- Liver International, 2007, v. 27, n. 8, p. 1119, doi. 10.1111/j.1478-3231.2007.01558.x
- By:
- Publication type:
- Article
Impact of non-alcoholic fatty liver disease on chronic hepatitis B.
- Published in:
- Liver International, 2007, v. 27, n. 5, p. 607, doi. 10.1111/j.1478-3231.2007.01482.x
- By:
- Publication type:
- Article
Microarray technology in the study of obesity and non-alcoholic fatty liver disease.
- Published in:
- Liver International, 2005, v. 25, n. 6, p. 1091, doi. 10.1111/j.1478-3231.2005.01183.x
- By:
- Publication type:
- Article
Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis.
- Published in:
- Liver International, 2005, v. 25, n. 4, p. 760, doi. 10.1111/j.1478-3231.2005.01117.x
- By:
- Publication type:
- Article
Association between Activity and Brain-Derived Neurotrophic Factor in Patients with Non-Alcoholic Fatty Liver Disease: A Data-Mining Analysis.
- Published in:
- Life (2075-1729), 2021, v. 11, n. 8, p. 799, doi. 10.3390/life11080799
- By:
- Publication type:
- Article
Review article: Hepatic steatosis and its associations with acute and chronic liver diseases.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 2, p. 167, doi. 10.1111/apt.18059
- By:
- Publication type:
- Article
Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis ‐ prevalence, clinical impact, economic implications and management strategies.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. S1, doi. 10.1111/apt.17833
- By:
- Publication type:
- Article
Review article: New developments in biomarkers and clinical drug development in alpha‐1 antitrypsin deficiency‐related liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 10, p. 1183, doi. 10.1111/apt.17967
- By:
- Publication type:
- Article
Design of the phase 3 MAESTRO clinical program to evaluate resmetirom for the treatment of nonalcoholic steatohepatitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. 51, doi. 10.1111/apt.17734
- By:
- Publication type:
- Article
Editorial: optimal combination of non‐invasive tests to determine significant fibrosis in non‐alcoholic fatty liver disease—authors' reply.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
The combination of the enhanced liver fibrosis and FIB‐4 scores to determine significant fibrosis in patients with nonalcoholic fatty liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 12, p. 1417, doi. 10.1111/apt.17472
- By:
- Publication type:
- Article
Letter: should we abandon FIB‐4 to characterise noninvasively patients with NAFLD? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 8, p. 922, doi. 10.1111/apt.17448
- By:
- Publication type:
- Article
Vigorous physical activity provides protection against all‐cause deaths among adults patients with nonalcoholic fatty liver disease (NAFLD).
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 6, p. 709, doi. 10.1111/apt.17308
- By:
- Publication type:
- Article
Editorial: let's get physical—long‐term benefits of vigorous physical activity in patients with nonalcoholic fatty liver disease. Authors' reply.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Editorial: changes of health‐related quality of life associated with hepatic disease severity and its improvement after treatment in NAFLD—authorsʼ reply.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
A practical use of noninvasive tests in clinical practice to identify high‐risk patients with nonalcoholic steatohepatitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 3, p. 304, doi. 10.1111/apt.17346
- By:
- Publication type:
- Article
Impairment of patient‐reported outcomes among patients with non‐alcoholic fatty liver disease: a registry‐based study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 2, p. 215, doi. 10.1111/apt.17301
- By:
- Publication type:
- Article
Review article: the epidemiologic burden of non‐alcoholic fatty liver disease across the world.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 6, p. 942, doi. 10.1111/apt.17158
- By:
- Publication type:
- Article
Letter: the use of Fibrosis‐4 score in primary care and diabetology practices—Occam's razor applied to advanced fibrosis screening. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 11/12, p. 1761, doi. 10.1111/apt.16091
- By:
- Publication type:
- Article
Editorial: a diabetologist's perspective on the diagnosis and monitoring of NAFLD—Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 4, p. 712, doi. 10.1111/apt.15929
- By:
- Publication type:
- Article
Clinical assessment for high‐risk patients with non‐alcoholic fatty liver disease in primary care and diabetology practices.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 3, p. 513, doi. 10.1111/apt.15830
- By:
- Publication type:
- Article
Validation of endogenous reference genes for qRT-PCR analysis of human visceral adipose samples.
- Published in:
- BMC Molecular Biology, 2010, v. 11, p. 39, doi. 10.1186/1471-2199-11-39
- By:
- Publication type:
- Article
The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH).
- Published in:
- BMC Medical Genetics, 2016, v. 17, p. 1, doi. 10.1186/s12881-016-0324-0
- By:
- Publication type:
- Article
Can Frequent Toothbrushing Reduce the Risk of Cirrhosis among Patients with Nonalcoholic Fatty Liver Disease? Hints from a Registry-Based Study.
- Published in:
- Digestive Diseases, 2023, v. 41, n. 6, p. 932, doi. 10.1159/000531981
- By:
- Publication type:
- Article
'Highly Plausible' GLP-1s Can Improve Health-Related QoL, Economic Burden of MASH.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 7, p. 7
- By:
- Publication type:
- Article
Modelling the economic and clinical burden of non‐alcoholic steatohepatitis in East Asia: Data from Hong Kong.
- Published in:
- Hepatology Research, 2020, v. 50, n. 9, p. 1024, doi. 10.1111/hepr.13535
- By:
- Publication type:
- Article
Knowledge-Based Identification of Soluble Biomarkers: Hepatic Fibrosis in NAFLD as an Example.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0056009
- By:
- Publication type:
- Article
Sofosbuvir and Ribavirin for Treatment of Chronic Hepatitis C in Patients Coinfected With Hepatitis C Virus and HIV: The Impact on Patient-Reported Outcomes.
- Published in:
- Journal of Infectious Diseases, 2015, v. 212, n. 3, p. 367, doi. 10.1093/infdis/jiv005
- By:
- Publication type:
- Article
Health utilities using SF-6D scores in Japanese patients with chronic hepatitis C treated with sofosbuvir-based regimens in clinical trials.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Predicting Liver-Related Outcomes in Steatotic Liver Disease.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 331, n. 15, p. 1274, doi. 10.1001/jama.2024.0799
- By:
- Publication type:
- Article
Health-Related Quality of Life in Chronic HCV-Infected Patients Switching to Pegylated-Interferon-Free Regimens (ANRS CO20 CUPIC Cohort Study and SIRIUS Trial).
- Published in:
- Patient, 2017, v. 10, n. 5, p. 605, doi. 10.1007/s40271-017-0232-1
- By:
- Publication type:
- Article
Prevalence of metabolic dysfunction‐associated steatotic liver disease in the Middle East and North Africa.
- Published in:
- Liver International, 2024, v. 44, n. 4, p. 1061, doi. 10.1111/liv.15852
- By:
- Publication type:
- Article
The use of current knowledge and non‐invasive testing modalities for predicting at‐risk non‐alcoholic steatohepatitis and assessing fibrosis.
- Published in:
- Liver International, 2023, v. 43, n. 5, p. 964, doi. 10.1111/liv.15555
- By:
- Publication type:
- Article
The impact of fatigue on mortality of patients with non‐alcoholic fatty liver disease: Data from National Health and nutrition examination survey 2005–2010 and 2017–2018.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2646, doi. 10.1111/liv.15437
- By:
- Publication type:
- Article